Takeda to pursue more M&A deals

Takeda Pharmaceuticals is planning to continue pursuing M&A deals aimed at strengthening its portfolio after the acquisition of Ariad Pharmaceuticals. James Kehoe, Takeda Pharmaceuticals’ chief financial officer, said on a…